234 related articles for article (PubMed ID: 25514772)
1. [Not Available].
Aktuelle Urol; 2014 Nov; 45(6):433. PubMed ID: 25514772
[No Abstract] [Full Text] [Related]
2. Risk of dying from early prostate cancer is low regardless of treatment, study finds.
White C
BMJ; 2016 Sep; 354():i4984. PubMed ID: 27633860
[No Abstract] [Full Text] [Related]
3. [Urologists introduce a new round of prostate specific antigen discussion].
Aktuelle Urol; 2013 Jul; 44(4):257-8. PubMed ID: 23904120
[No Abstract] [Full Text] [Related]
4. [Early diagnosis of prostate cancer].
Hocaoglu Y; Seitz M; Stief CG; Bastian PJ
MMW Fortschr Med; 2012 Jan; 154(1):43-6. PubMed ID: 22642003
[No Abstract] [Full Text] [Related]
5. Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.
Shen X; Kumar P
J Urol; 2016 May; 195(5):1397-1402. PubMed ID: 26656266
[TBL] [Abstract][Full Text] [Related]
6. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
7. The dilemma of prostate-specific antigen testing.
Leach R; Thompson IM
Arch Intern Med; 2012 Jun; 172(11):835-6. PubMed ID: 22905350
[No Abstract] [Full Text] [Related]
8. The current management of carcinoma of the prostate.
Rodriguez R; Carter HB
Adv Surg; 1999; 33():181-97. PubMed ID: 10572567
[No Abstract] [Full Text] [Related]
9. [New developments in diagnosis and therapy of prostate cancer--from "active surveillance" to robotic-assisted surgery].
Krome S
Dtsch Med Wochenschr; 2011 Oct; 136 Suppl 3():S86-9. PubMed ID: 21960373
[No Abstract] [Full Text] [Related]
10. [You have to take the prostate cancer seriously].
Stief CG
MMW Fortschr Med; 2012 Jan; 154(1):42. PubMed ID: 22642002
[No Abstract] [Full Text] [Related]
11. A critical need for national guidelines.
Osanto S; van Poppel H
Onkologie; 2010; 33(7):351-2. PubMed ID: 20631480
[No Abstract] [Full Text] [Related]
12. [Standards for the punch biopsy of the prostate].
Seitz M; Schlenker B; Gratzke C; Weidlich P; Stief CG; Reich O
MMW Fortschr Med; 2007 Jan; 149(4):35-6. PubMed ID: 17615715
[TBL] [Abstract][Full Text] [Related]
13. [Tumor marker in prostate cancer].
Arai Y
Nihon Hinyokika Gakkai Zasshi; 1994 Nov; 85(11):1575-92. PubMed ID: 7528825
[No Abstract] [Full Text] [Related]
14. Guideline of guidelines: prostate cancer screening.
Loeb S
BJU Int; 2014 Sep; 114(3):323-5. PubMed ID: 24981126
[No Abstract] [Full Text] [Related]
15. [Detection of prostate cancer. German guideline recommends opportunist screening].
Arnheim K
MMW Fortschr Med; 2010 Sep; 152(39):12-3. PubMed ID: 21058430
[No Abstract] [Full Text] [Related]
16. The Risk of Distant Metastases and Cancer Specific Survival in Men with Serum Prostate Specific Antigen Values above 100 ng/ml.
Stattin K; Sandin F; Bratt O; Lambe M
J Urol; 2015 Dec; 194(6):1594-600. PubMed ID: 26192253
[TBL] [Abstract][Full Text] [Related]
17. Prostate Cancer Screening - A Perspective on the Current State of the Evidence.
Pinsky PF; Prorok PC; Kramer BS
N Engl J Med; 2017 Mar; 376(13):1285-1289. PubMed ID: 28355509
[No Abstract] [Full Text] [Related]
18. [Screening and prevention of prostate cancer].
Roosen A
MMW Fortschr Med; 2010 May; 152(19):37-9. PubMed ID: 20557000
[No Abstract] [Full Text] [Related]
19. Conflicting clinical guidelines.
Schmidt C
J Natl Cancer Inst; 2013 Jan; 105(1):2-3. PubMed ID: 23257157
[No Abstract] [Full Text] [Related]
20. [A paradigm shift. Defensive strategies for the treatment of localized prostate cancer in the new S3 guideline].
Weissbach L; Schaefer C; Heidenreich A
Urologe A; 2010 Feb; 49(2):199-205. PubMed ID: 20180059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
